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Cysteine is susceptible to a variety of modifications by reactive oxygen and nitrogen
oxide species, including glutathionylation; and when two cysteines are involved, disulfide
formation. Glutathione-cysteine adducts may be removed from proteins by glutaredoxin,
whereas disulfides may be reduced by thioredoxin. Glutaredoxin is homologous to the
disulfide-reducing thioredoxin and shares similar binding modes of the protein substrate.
The evolution of these systems is not well characterized. When a single Cys is present
in a protein, conjugation of the redox buffer glutathione may induce conformational
changes, resulting in a simple redox switch that effects a signaling cascade. If a second
cysteine is introduced into the sequence, the potential for disulfide formation exists.
In favorable protein contexts, a bistable redox switch may be formed. Because of
glutaredoxin’s similarities to thioredoxin, the mutated protein may be immediately exapted
into the thioredoxin-dependent redox cycle upon addition of the second cysteine. Here we
searched for examples of protein substrates where the number of redox-active cysteine
residues has changed throughout evolution. We focused on cross-strand disulfides (CSDs),
the most common type of forbidden disulfide. We searched for proteins where the CSD
is present, absent and also found as a single cysteine in protein orthologs. Three different
proteins were selected for detailed study—CD4, ERO1, and AKT. We created phylogenetic
trees, examining when the CSD residues were mutated during protein evolution. We posit
that the primordial cysteine is likely to be the cysteine of the CSD which undergoes
nucleophilic attack by thioredoxin. Thus, a redox-active disulfide may be introduced into
a protein structure by stepwise mutation of two residues in the native sequence to Cys.
By extension, evolutionary acquisition of structural disulfides in proteins can potentially
occur via transition through a redox-active disulfide state.
Keywords: cross-strand disulfide, forbidden disulfide, redox-active disulfide, exaptation, disulfide evolution, CD4
evolution, AKT evolution, post-translational cysteine modification
INTRODUCTION
Thiol-based redox signaling is the collective name for biochemi-
cal pathways that regulate cellular processes by post-translational
modification of sulfur moieties in cysteine (Cys) and methio-
nine (Met) residues of proteins. These pathways are patholog-
ically dysregulated in diseases of oxidative stress which include
cancer, neurodegenerative diseases, heart disease and aging. A
better understanding of these pathways is essential to diagnosis,
treatment, and prevention of these diseases.
Cys residues are susceptible to a variety of modifications by
reactive oxygen and nitrogen oxide species (ROS, RNS). Cys can
be nitrosated, glutathionylated, and can form covalent bonds
with other Cys. RNS such as nitric oxide (•NO) can mediate
S-nitrosation to yield an S-nitrosothiol (RSNO). Other RNS, such
as peroxynitrite (ONOO–), can also mediate S-nitration to yield
S-nitrothiols (RSNO2). Sequential oxidation of Cys thiols yields
sulfenic (–SOH), sulfinic (–SO2H), or sulfonic (–SO3H) acid
derivatives. Reaction of protein thiols with low-molecular weight
thiols such as glutathione (GSH) can yield mixed disulfides.
Alternatively, oxidation by ROS or RNS can result in a disulfide
bridge forming between two thiols, either within a protein chain
or between protein chains (Wouters et al., 2011).
Reduction of these systems is effected in a variety of ways. For
some disulfides, autoreduction within a protein may be assisted
by mechanical stresses and the local electrostatic environment.
For example, arsenate reductase (ArsC), an enzyme involved in
detoxification of arsenic, transfers electrons through a series of
Cys modifications, manifested largely as disulfide isomerizations,
as part of its catalytic cycle (Messens et al., 2002). Two of the three
disulfides formed in the oxidized states of ArsC are autoreduced,
while the disulfide in the final oxidized state is reduced by thiore-
doxin (Trx) (Messens et al., 2002;Wouters et al., 2010). In general,
www.frontiersin.org March 2015 | Volume 6 | Article 1 | 1
Mohanasundaram et al. Role of GSH in evolution of thiol-based redox signaling
reduction of surface accessible disulfides may be effected by the
GSH redox buffer (Ostergaard et al., 2001), or specific thiol oxi-
doreductases such as Trx. GSH-Cys adducts may be reduced by
glutaredoxins (Grxs), which are homologs to Trxs (Martin, 1995),
and share similar binding modes of the protein substrate with
Trxs.
It is now understood that a continuum of redox set points
within proteins control cellular processes in response to a range
of ROS fluxes. Low fluxes mediate homeostatic control of house-
keeping redox processes, while higher fluxes mount stress and
adaptive responses before a threshold is reached, triggering apop-
tosis, or programmed cell death. Partial loss of control of these
processes is now believed to underlie aging (Humphries et al.,
2006). Even higher levels of ROS can cause cellular necrosis.
In addition to its roles in housekeeping and the stress response,
thiol-based redox regulation is also important in developmental
processes in plants and animals. In plants, thiol-based redox reg-
ulation is involved in seed germination (Buchanan, 1980). In ani-
mals, the early embryo forms under reducing conditions (Hartley,
1960), but the embryonic environment becomes more oxidizing
as the embryo grows (Hartley, 1960; Ibrahim et al., 2006). Redox-
regulated processes govern the formation of substructures during
embryo development by selective apoptosis.
The evolution of these systems is not well characterized.
Among prokaryotes, the well-studied GSH system of eukaryotic
redox regulation operates only in purple bacteria and cyanobac-
teria (Fahey, 2001; Mallick et al., 2002). In other prokaryotes,
different redox buffers are utilized, for example acetyl-coenzyme
A in gram positive bacteria (Hummel et al., 2005). It appears
that the role of GSH as a redox buffer is predated by its role
in detoxification. Glutathione S-transferases (GSTs) label xeno-
biotics with GSH, allowing them to be removed from the cell
by specific transporters. GSTs are found in all classes of eukary-
ota and bacteria. Within GSTs, the GSH-conjugating site lies in a
Trx-like domain (Atkinson et al., 2009). These data suggest that
a common stress-related ancestor with a Trx-like fold may have
pre-dated the evolution of the thiol-oxidase function now most
commonly associated with the Trx-like fold.
In its role as a redox buffer, GSH is conjugated to reactive Cys
of endogenous proteins, inducing conformational changes in the
substrate proteins, and effecting a signaling cascade that evokes
biological responses (Wouters et al., 2011). Conformational
changes are generally small, involve the protein backbone, and are
often accompanied by a local increase in protein disorder (Mallis
et al., 2000;Wouters et al., 2011). Surface modification of proteins
such as carbonic anhydrase by GSH results in significant disorder
of the GSH distal to the covalent bond (Mallis et al., 2000). In
this disordered state, GSH may act as a flipper, disrupting protein
interactions. Thus, introduction of a single Cys into a protein may
allow reversible GSH conjugation to occur, effectively introducing
a simple redox switch into the protein.
If a second Cys is introduced into the protein sequence, the
potential for disulfide formation exists. In favorable configura-
tions and protein contexts, a bistable redox switch may be formed
(Wouters et al., 2010). This has the potential to effect two dif-
ferent “active” states of the protein. For example, the protein may
interact with certain protein partners with the switch in one redox
state, and with other protein partners when the switch is in the
alternate redox state.
How are these redox-regulated sites introduced into proteins?
The introduction of potential disulfide-forming thiol pairs may
be facilitated by the fact that both Cys do not need to be intro-
duced into the protein chain simultaneously. This may seem
obvious in isolation but, in toto, a number of constraints must be
satisfied, and the likelihood of this occurring is greatly increased
if the process can occur in a stepwise manner. Incorporation of
a single Cys may make the protein immediately responsive to a
range of oxidative modifications, including nitrosation and glu-
tathionylation (Figure 1). In order for these modifications to be
effective, the context of the Cys within the protein must be suit-
able. To be modifiable, the Cys must have a low pKa, a property
that is largely determined by the electrostatic environment of the
protein context. In addition, in order for GSH to be reductively
removed from the Cys, Grx must be able to dock to the backbone
near the modified Cys. Thus, there are additional requirements
on the secondary structure and accessibility of the introduced Cys
residue. Introduction of a second Cys at a later stage may then
enable disulfide formation subject to further constraints. Because
Grxs are homologs to Trxs and share similar binding modes of
the protein substrate, the complete redox cycle may potentially be
immediately effected. So the similarity in the constraints of 1-Cys
and 2-Cys reduction facilitates this second Cys acquisition step,
but an additional constraint is that the second Cys must be the
resolving Cys and thus have a higher pKa than the existing Cys.
Anecdotally, a number of these 1-Cys/2-Cys homologs have
been described (Wouters et al., 2010). An example where one
protein is glutathionylated and a homolog forms disulfides is the
Grx–Trx pair itself. Trx forms a disulfide between the Cys residues
of the CXXC motif as part of its reaction cycle. Grx contains
only the reactive N-terminal Cys of the CXXC motif which is glu-
tathionylated during its reaction cycle. Another pair of families is
the 1-Cys and 2-Cys peroxiredoxins (Prxs) (Copley et al., 2004).
When the resolving Cys is present, Prxs are reduced by Trx. When
it is not, they are reduced by Grx. In all the above examples, the
additional Cys is the resolving Cys, suggesting the reactive Cys
must come first in order for the mutation to become fixed in
the population. These examples demonstrate evolutionary exap-
tation from the Grx pathway to the Trx pathway, or vice versa,
does occur; and likely can be easily effected for other proteins.
The vast database of sequenced genomes of organisms is a
valuable resource which can be mined for information regarding
the evolution of these pathways, leading to a better understanding
of their function and control. Here we searched for examples of
protein substrates where the number of redox-active Cys residues
has changed throughout evolution.
We focused on cross-strand disulfides (CSDs), a type of forbid-
den disulfide motif. Forbidden disulfides are a group of canonical
disulfides that disobey elucidated rules of protein stereochem-
istry (Wouters et al., 2010). CSDs are metastable disulfides: their
intermediate disulfide torsional energies render than more easily
reduced than low energy structural disulfides, but they are more
stable than high energy disulfides (Wouters et al., 2007, 2011).
Their reduction is likely assisted by endogenous proteins. The
postulated role of CSDs as canonical redox switches is supported
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FIGURE 1 | Panels depict biochemical redox cycles of (A) single Cys and
(B) disulfide-forming pair of Cys residues and their evolution (white
central vertical panel). Incorporation of a single Cys (α) may make the
protein immediately responsive to a range of oxidative modifications,
including nitrosation and glutathionylation. Cys with lower pKas are more
susceptible to modifications. Introduction of a second Cys (β) at a later stage
may then enable disulfide formation, preventing overoxidation of the low pKA
“active” Cys and effectively forming a bistable redox switch. Because Grxs
are homologs to Trxs and share similar binding modes of the protein
substrate, the complete redox cycle may potentially be immediately effected.
These evolutionary modifications are reversible i.e., the resolving Cys may be
lost, returning the protein to the Grx pathway etc.
by anecdotal information underpinning a functional redox role
in specific examples (Haworth and Wouters, 2013). In particu-
lar, several CSDs are known Trx substrates (Maeda et al., 2005),
and we have postulated recently that CSDs are, in general, cognate
substrates of Trx (Haworth and Wouters, 2014).
Here, we focused specifically on protein orthologs where the
CSD is present, absent and also found as a single Cys. We pro-
vide a number of examples and speculate on the evolutionary
advantages of the changes.
MATERIALS AND METHODS
We mined the Protein databank (PDB) (Berman et al., 2000)
for proteins with CSDs, the most common type of forbidden
disulfide. In a dataset of 29,261 disulfide-containing proteins,
195 unique protein clusters containing 235 CSDs were retrieved
(Haworth and Wouters, 2013). These proteins were mapped to
Uniprot (Magrane and Consortium, 2011) using the PDB iden-
tifiers. For each protein sequence in this CSD set, sequences in
the corresponding 50% cluster of homologs from Uniprot were
retrieved and aligned.
SELECTION OF PROTEINS FOR STUDY
The proteins used in this study were chosen from the above
list based on two criteria—firstly, that there was good sequence
evidence (i.e. more than one ortholog) that an intermediate 1-Cys
state for the protein existed, and was retained in some species;
and secondly, that there was evidence that the protein was redox
regulated. From this set of CSD-containing proteins, three differ-
ent proteins were selected for detailed study—CD4, ERO1, and
AKT1. A fourth protein, DAPP1, satisfied the first criterion, but
because we could find no evidence supporting its redox activity,
it was not considered further. The corresponding identifiers for
the selected proteins in Uniprot were P01730 (CD4_HUMAN),
Q96HE7 (ERO1A_HUMAN), and P31749 (AKT1_HUMAN).
Data for the corresponding protein structures 4h8w, 3ahq, and
1unr was retrieved from PDBsum (De Beer et al., 2014).
MULTIPLE SEQUENCE ALIGNMENT AND TREE GENERATION
For each seed sequence, an initial alignment was performed
in Uniprot using the sequences in the 50% sequence identity
cluster (Clusterref_50) with the “Align” option. The raw mul-
tiple sequence alignment from Uniprot was loaded into Jalview
(2.8.1) (Waterhouse et al., 2009) for editing, visualization and
analysis. Masking was performed to remove ambiguous regions
of the alignment, and the initial tree was generated with the
Neighbor-joining method using the BLOSUM 62 substitution
matrix. Additional sequences were added to the alignment using
a combination of Blast searches (Altschul et al., 1990) of Uniprot,
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and joining of additional 50% sequence identity (ID) clusters to
provide further evolutionary depth when necessary. The gener-
ated tree in Newick format was loaded into the evolutionary tree
builder MEGA6 (Tamura et al., 2013) and the root chosen using
an outgroup from the accepted species tree (Murphy and Eizirik,
2009). The figure for the final tree was created inMEGA6 and fur-
thermanipulated in Illustrator 6 (Adobe Systems). The number of
Cys residues in the CSD motif was mapped onto the phylograms
manually.
CD4
For CD4, the human cluster Uniref50_P01730 containing 42
sequences from 20 different species was initially retrieved.
Multiple sequences were excluded: including 15 partial sequences,
seven Refseq sequences, an uncharacterized protein, a testis cDNA
sequence and two surface antigen sequences; resulting in an ini-
tial alignment built on 16 sequences from seven different species.
Since the sequences in the cluster did not provide enough evolu-
tionary information, we extended our analysis using a Blast search
(Altschul et al., 1990) in Uniprot using P01730 as a template. The
results from the Blast search were again filtered, excluding alter-
nate isoforms from the same species, resulting in an additional
125 CD4-like sequences being added to the alignment. Masking
was performed to remove alignment ambiguities near gaps. As the
alignment was ambiguous in the region of the CSD in fishes, tur-
tle, duck, snakes, and frogs, these sequences were excluded from
further consideration. The final tree was built on an alignment
of 51 sequences from 50 different species using residues homol-
ogous to 85–129, 150–230, 233, 236–244, 281–302, 307–348, and
351–373 of the human sequence. The disulfide of interest forms
between Cys residues at positions 154 and 184 of the human
sequence P01730 (130 and 159 in the PDB structure: 4h8w). The
complete phylogram is shown in Supplementary Figure 1. Further
analysis of sequence conservation was performed with Jalview on
sequence subsets. In one subset, the sequences of 16 primate and
three muroid sequences, where the disulfide was conserved, were
analyzed separately in the vicinity of the CSD. In two additional
subsets, separate pairwise alignments of human and galago CD4,
and mouse and Chinese hamster CD4 were performed as a part
of more detailed analyses (Supplementary Figure 2).
ERO1
For ERO1, the cluster Uniref50_Q96HE7 built on the human
sequence, containing 66 protein sequences from 37 species,
was used in the initial alignment. Most of the sequences were
ERO1A and ERO1B genes in higher animals. In order to retrieve
more evolutionary information, a Blast search was performed
in Uniprot using the human ERO1A protein Q96HE7 as the
template. This retrieved ERO1-like sequences from divergent
species including worms, beetles, lancelet, fishes, fruit flies, and
mosquitoes. The 50% identity cluster Uniref50_L7MC09 built
on the Rhipicephalus pulchellus sequence, with sequences from
lancelet (C3Z2H2), red flour beetle and polychaete worms, was
incorporated, and an additional Blast search using the ERO1
protein of Capitella teleta (Polychaete worm) was performed.
The resulting alignment of 177 sequences was further refined by
choosing a representative sequence for branches with very small
branch lengths. Masking was performed and a tree built from the
final alignment containing 119 sequences using regions 33–58,
61–103, 108–115, 137–144, 157–160, 174–210, 239–270, 275–287,
295–324, 328–335, 338–363, 371–386, 390–393, 402–418, 433–
438, and 444–456 homologous to the human ERO1. A Newick
tree was generated in Jalview and loaded into MEGA6, where
the Black flying fox sequence (Uniprot id: L5K102) was chosen
as the root. The two CSDs of interest are nested in the sequence
at positions 35 and 48 and 37 and 46 (PDB: 3ahq and Uniprot:
Q96HE7). A complete phylogram is shown in Supplementary
Figure 3.
AKT
For AKT, the Uniref50_P31751 cluster was retrieved with 121
sequences from 69 organisms. Of these, 54 sequences from 38
different organisms, from human to snake, were mapped to
Uniprot and the initial alignment was built. This was merged
with UniRef50_Q17941, a 50% sequence ID cluster built on
Caenorhabditis elegans AKT1 (Q17491) which mapped to 19
Uniprot sequences from 18 different organisms, mostly arthro-
pods; and the 50% cluster Uniref50_Q9XTG7 built on C. elegans
AKT2 with nine mapped sequences from sea squirt, C. vulgaris
and platyfish. A Blast search was performed with the Honeybee
AKT1 (H9KF44) as the template. After removing the duplicates,
the resulting sequences were aligned in Uniprot and merged with
the previous alignment. After masking, the final alignment was
built with 262 sequences with residues 28–45, 48–71, 76–113,
146–210, 215, 230–266, 269–302, and 335–427 homologous to
the human AKT1 protein P31749. A Newick tree was generated
and loaded into MEGA6. The land crab sequence was chosen as
the root. The disulfide of interest is formed between Cys 60 and
Cys 77 of the human AKT1 protein (PDB: 1unr and Uniprot:
P31749). The complete phylogram is shown in Supplementary
Figure 4.
PHYSICOCHEMICAL PROPERTIES OF CSDs
To further investigate the lability of the CSDs of interest we
calculated the torsional energies of the disulfide bonds; and,
where possible, the pKas of the two involved Cys. Torsional
energy calculations were performed using an online torsional
energy calculator1 based on input dihedrals, which uses a com-
bined quantum chemical (χ2,χ3,χ
′
2) and empirical calculation
(χ1,χ
′
1) described in detail elsewhere (Haworth et al., 2010).
Dihedral angles were calculated using Pymol2. Calculations of pKa
for individual Cys residues were performed with Propka3 which
gives an approximation of the pKa based on a solution of the
Boltzmann equation (Rostkowski et al., 2011). The only reduced
structure available was for AKT (PDB: 1unq).
RESULTS
We previously mined the PDB for proteins with CSDs, the most
common type of forbidden disulfide (Haworth and Wouters,
2014). Forbidden disulfides are strained disulfides that occupy
1http://www.sbinf.org/applications/pes.html
2http://www.pymol.org/
3http://propka.org
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recognizable contexts in primary and secondary structure of
proteins. The contexts were originally declared “forbidden” by
analyses that considered the geometric constraints of disulfide
formation and hydrogen bond formation in secondary struc-
ture (Richardson, 1981; Thornton, 1981). Later work has shown
that disulfides in these strained contexts do occur, despite their
strain, which likely relates to their functional redox role in pro-
teins (Wouters et al., 2010; Haworth and Wouters, 2013). The
frequency of CSDs in solved protein structures is increasing,
likely due to better control of redox conditions during structure
solution (Wouters et al., 2010). Because CSDs can act as redox
switches, failure to control conditions carefully results in the
proteins adopting different structural states. This heterogeneity
adversely affects the crystallization process.
CSDs have been introduced into protein sequences extensively
throughout evolution, especially in molecules of the immune
system, particularly the adaptive immune system (Wouters et al.,
2007). In order to study this process in the selected proteins of
interest, we scanned homologs of proteins with CSDs for sets
where the disulfide was not completely conserved. Three proteins
were chosen where a CSD has been introduced relatively recently
in evolutionary history; and where the 1-Cys evolutionary inter-
mediate state was preserved in some species: CD4, ERO1, and
AKT. For each of these proteins, alignments of the homologs were
created from Uniprot clusters and Blast searches. Alignments
were masked and evolutionary trees created as described in detail
in the methods.
CD4
CD4 is a critical protein of the adaptive immune system, which
may be expressed on the surface of some lymphocytes, including
T helper cells, monocytes, macrophages, and dendritic cells. CD4
T helper cells signal to other immune cells, such as CD8 killer
cells, to alert them to the presence of infectious agents whichmust
be targeted. CD4 is a co-receptor for major histocompatibility
complex (MHC) class II molecules, and the primary cell sur-
face receptor for Simian immunodeficiency virus (SIV)/Human
immunodeficiency virus (HIV) (Dalgleish et al., 1984).
In CD4+ T cell antigen receptor-mediated signaling, the poly-
morphic regions of the MHC class II proteins engage the recep-
tor complex, whereas the non-polymorphic regions engage the
CD4 co-receptor (Parnes, 1989). The TCR/MHCII/CD4 super-
complex then recruits intracellular molecules such as LCK to
effect signaling.
The CD4 molecule is a single-pass transmembrane protein
with 4 extracellular immunoglobulin (Ig) domains and a short
cytoplasmic tail. The Ig domains comprise a duplication of a
pair of Ig variable (IgV) and Ig constant (IgC) domains arranged
in tandem (Figure 2B). Structurally, IgV domains are slightly
larger than IgC domains, having more strand elaborations on
the basic Ig domain fold (Halaby et al., 1999). Ig domains are
extremely common domains that are frequently involved in
redox regulation (Wouters et al., 2010; Haworth and Wouters,
2013). Ig domains and their antecedents, the fibronectin type III
(FIII) domains are found in many proteins of both the innate
and adaptive immune system including cytokine receptors (FIII
domains); and Ig domain-containing MHC homologs such as
MICA and RAE-Iβ (Wouters et al., 2007). Ig domains consist of
two β sheets that form a sandwich, typically containing seven
to nine strands. The seven-stranded variety is labeled from A to
G. Additional strands in larger Ig domains (such as the variable
domains) are typically found between the C and D strands and
are labeled C′, C′′ etc. In general, Ig domains are distinguished
from FIII domains by an intersheet disulfide that links strand B
on one sheet to strand F on the other.
Three regions of CD4 have been implicated to date in impor-
tant protein-protein interactions (Figure 2B). The region of
human CD4 that interacts with MHC class II lies mainly within
the C′′ and D strands of domain 1 (D1), the N-terminal IgV
domain (Wang et al., 2001). A second region, located in the short
cytoplasmic tail, is a CXCmotif that mediates the interaction with
lymphoid cell kinase (LCK or p56LCK) necessary for T cell acti-
vation (Laing et al., 2006). The third region, which contains the
CSD of CD4, is located in D2, the N-terminal IgC domain, joining
two β-hairpins. The CSD is formed by a disulfide bond between
Cys 130 and Cys 159 in the structure (PDB: 4h8w).
The CSD has been demonstrated to be reduced during the
process of T-cell signaling, and its reduction is also co-opted
during entry of the HIV viral envelope glycoprotein (gp120)
into the cell. During T-cell signaling, it must be reduced in
order for the TCR/MHCII/CD4 receptor complex to form: a
process that requires CD4 dimerization and domain swapping
(Cerutti et al., 2014). Reduction of the CD4 CSD is mediated
by Trx, Grx1, and PDI in vitro (Gallina et al., 2002; Matthias
et al., 2002; Auwerx et al., 2009). Further investigation of the
role of the CSD of CD4 in T-cell signaling has recently been
performed using four Cys mutants: C159A, a mutant of the
putative active Cys of the CSD; C16A/C84A, a double mutant
deleting the disulfide from D1; C130A/C159A, a CSD deletant;
and C16A/C84A/C130A/C159A, a D1 disulfide and CSD deletant
(Cerutti et al., 2014). Experiments with these mutants demon-
strated that CD4 binds gp120 of HIV as a reduced monomer; and
that CD4 requires reduction of either the D1 or the D2 disulfide to
bind gp120, but not both (Cerutti et al., 2014). A redox potential
of -241mV has been determined for the CSD by titration against
DTT (Matthias et al., 2010). The higher efficiency of Trx reduc-
tion of the CSD suggests the reduction is likely performed by Trx
in vivo (Cerutti et al., 2014).
The phylogenetic tree for CD4, built from 51 sequences from
50 species is shown in Figure 2A. CD4 is thought to have arisen
relatively recently in teleost fish following duplication of a two Ig
domain-containing ancestral gene, CD4REC (Laing et al., 2006).
In trout, CD4, CD4REC and the related protein lymphocyte-
activation gene 3 (LAG3) share many similar features (Figure 2B)
(Laing et al., 2006). The CSD is not present in D2 of trout CD4
which instead contains a disulfide between strands B and F (Laing
et al., 2006), typical of most Ig domains (Halaby et al., 1999).
The full alignment shows that between the divergence of bony
fish and chicken, the Cys on strand B was lost by mutation.
The homologous residue is a leucine (Leu) (143 in P01730 and
118 in PDB: 4h8w) in human CD4, and a single unpaired Cys
residue remains on strand F in D2 of the chicken sequence. It
seems likely this single Cys is a glutathionylation site in chicken.
Based on the phylogenetic tree, the acquisition of the second
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FIGURE 2 | Evolution of CD4 (A) phylogenetic tree in mammals. The
color of the branches indicates the number of Cys of the CSD motif in
D2. The CSD is found in species with red branches. Species with purple
branches have only the C-terminal Cys. The CSD was likely acquired in
primates (A–D) around 75 MYA, and independently in muroid rodents viz
mice, rats (O) and hamsters (P), after the divergence of squirrels (Q,
sciuridae), also around 75 MYA. Acquisition of the CSD in muroids was
accompanied by rapid evolution of the CD4 protein as evidenced by the
long branch lengths of this clade (upper red branches). The four major
clades of Eutherian mammals are Afrotheria (including elephants E);
Xenartha (none depicted); Laurasiatheria (F–L, shown in pink) and
Euarchontaglires (primates, A–D, green circle; glires, N–S yellow circle;
and treeshrews, M) (Murphy et al., 2001) Key: A, Lesser apes; B, Greater
apes; C, Marmoset (Platyrhines); D, Galago; E, African Elephant; F, Bats;
G, Panda/Mink/Ferret; H, Dog and cat; I, Pig; J, Dolphin, Whale and
Camel; K, Sheep, Bovine, Goat; L, Horse; M, Tree shrew; N, Rabbit; O,
Mouse and rat; P, Chinese hamster; Q, Squirrel/wood chuck; R, Guinea
pig; S, Mole rat; T, Wallaby and opossum; U, Platypus. (B) Evolution of
CD4 and related molecules showing important thiol-containing sites.
Molecules are depicted from the more ancestral forms of the molecule
(leftmost) to more recently evolved forms to the right. The CD4
homologs consist of two to four extracellular Ig domains, a single
transmembrane region and a short cytoplasmic tail. Three important
thiol-bearing functional sites have been identified: the CXC motif in the
cytoplasmic tail, the between-sheet disulfide in D1, and the cross-strand
disulfide (CSD) in D2. The CXC motif is present in all CD4 orthologs
(β–ε), but not in the CD4-like LAG3 molecule. The between-sheet
disulfide in D1 is present in CD4 and LAG3 (α–ζ). In some teleosts, such
as trout and fugu, the Cys on strand B is lost, leaving a single unpaired
Cys on strand F. D1 can be definitively identified in CD4REL because it
is distinctively encoded on two exons in molecules β–ε (Laing et al.,
2006). It is involved in interaction with MHC II molecules. Thiols in the
D2 site have evolved over time. Originally D2 contained Cys residues on
strands B and F, typical of Ig domains (α–γ). Around 250 MYA, the thiol
on strand B was lost (δ–ε). Around 75 MYA, a new thiol appeared on
strand C allowing the novel CSD to form upon oxidation (ζ). α–γ are
CD4-like proteins which evolved in a trout ancestor around 450 MYA.
Interacting proteins are shown in gray: all proteins bind MHC class II;
the CD4-related molecule LAG3 (α) binds MHC but not LCK. D3 and D4
contain glycosylation sites which may serve to fend off adventitious
interactions with other membrane proteins (Laing et al., 2006). Ig
domains are depicted as bisected hexagons with each half representing
one sheet: V-like domains are depicted in green; C-like domains in
magenta. A CXXC motif in LCK binds to the CXC motif of CD4 via Zn2+
(depicted as a blue diamond) (Lin et al., 1998). The extracellular and
cytoplasmic sides of the membrane are labeled on the right.
Frontiers in Pharmacology | Experimental Pharmacology and Drug Discovery March 2015 | Volume 6 | Article 1 | 6
Mohanasundaram et al. Role of GSH in evolution of thiol-based redox signaling
Cys on strand C enabling CSD formation likely occurred inde-
pendently in two different clades, both within euarchontaglires,
one of four large clades of placental mammals (Murphy and
Eizirik, 2009). The tree in Figure 2A shows only mammals. The
CSD is found in primates, which emerged around 75 million
years ago (MYA); and was acquired independently in muroid
rodents (mice, rats, and hamsters), after the divergence of squir-
rels (sciuridae), also around 75 MYA (Murphy and Eizirik, 2009).
Acquisition of the CSD in both clades was accompanied by rapid
evolution of the sequence between the two Cys residues in D2,
as shown in the partial alignment in Figure 3 and in the full pair-
wise sequence alignments in the supplementary data (Figures S2b,
S2c). The pairwise identity for the entire CD4 molecule between
human and galago is 74%, and between rat and chinese ham-
ster is 66%; but the pairwise sequence identity over a 52-residue
window surrounding the CSD is 63% for the pairwise primate
sequences, and 44% for the pairwise muroid sequences. This
demonstrates that rapid remodeling of the sequence surround-
ing the CSD has occurred during the last 75 MYA in both the
primate and muroid clades. See further notes on this event in the
Discussion.
ERO1A (ENDOPLASMIC RETICULUM OXIDASE)
ERO1 is an essential oxidoreductase involved in disulfide for-
mation of nascent proteins in the endoplasmic reticulum (ER).
It acts by reoxidising protein disulfide isomerase (PDI), the
enzyme catalyzing disulfide formation. It has been extensively
studied in yeast (Frand and Kaiser, 1998). The protein contains
multiple redox-active disulfide bonds. In human ERO1, two
disulfide-forming Cys pairs, Cys 94/Cys 99 and Cys 394/Cys
397, constitute the redox-active enzymatic center. The first pair
of thiols are regulated via isomerisation with a second pair of
redox-active thiols to form a pair of nested disulfides between
non-consecutive Cys in the sequence (Cys 99–Cys 104, Cys
94–Cys 131) (Hansen et al., 2012).
Near the N-terminus of the sequence, two additional disulfides
which form a nested pair, are the CSDs present in the structure
of human ERO1 (Figure 4B). In the human sequence, the two
CSDs are formed between Cys 35 & Cys 48 and Cys 37 & Cys 46.
These disulfides are deemed to have a “structural role” because
they do not appear to be involved in thiol-disulfide exchange with
the enzymatic center (Inaba et al., 2010), nor are they conserved
across all ERO1 genes. However, the identity of these two disul-
fides as CSDs suggests a redox role, possibly as substrates of a
Trx-like enzyme (Haworth and Wouters, 2013). The role of the
Cys residues of the N-terminal thiol region (NTR) has not been
investigated by mutation but constructs of human ERO1A and
yeast ERO1 lacking the NTR are often used for functional assays
(Cabibbo et al., 2000; Sevier et al., 2007; Hansen et al., 2012). This
region may have a regulatory role.
FIGURE 3 | Multiple sequence alignment of CD4 in the region of the
CSD in species where both Cys are conserved (upper panel) and
measures of its conservation (lower panel) across two groups:
primates and muroids (purple), and primates only (green). For each
group, the conservation of the amino acid residue in each column, quality
(BLOSUM62 score based on observed substitutions) and consensus (most
common residue and its proportion for each column) as determined by
Jalview (Waterhouse et al., 2009) is shown. The sequence alignment of
CD4 showed less conservation in the vicinity of the CSD motif. In the
portion depicted, the average conservation across the primate + muroid
lineages is 6.2 for residues 53–80 (CSD region highlighted in yellow) and
7.9 within the primate group.
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FIGURE 4 | (A) Evolution of the ERO1 gene family. Branches are colored
according to the number of Cys present in the NTR of each species, as
shown in the legend. A single ERO1-like ancestral gene (pink background)
is present in eukaryotes from yeast to lamprey (J–P). With the exception
of plants (P), the majority of these genes have four Cys in the NTR (red
branches). ERO1 duplicated prior to the divergence of bony fishes. ERO1A
(green background) genes retained the nested Cys motif, as does ERO1B
(yellow background) in early diverging species such as fish, sharks, and
amphibians (F, G). However, later diverging species such as birds, reptiles,
and mammals (H, I) have only two Cys, homologs to the inner pair of
CSD-forming Cys. Plants (P) have an additional Cys, C-terminal to the
nested Cys motif. Selective loss of Cys residues has resulted in a single
N-terminal Cys in some ERO1 genes (purple branches) such as in ERO1L
in tapeworm (O) and Silk moth (K), and ERO1B in the Japanese ricefish.
Key to branches: A, Mammals; B, Birds; C, Frog and turtle; D, Shark and
Spotted gar; E, Fish; F, Fish; G, Shark, Frog and Coelacanth; H,
Birds/Snake/Chameleon; I, Mammals; J, Sea squirt/Oyster/Sea urchin; K,
Flies (Mosquito/Beetle/Bugs); L, Ants; M, Lancelet and Polychaete worm;
N, Worms; O, Tapeworms; P, Plants. (B) Line diagram of ERO1 showing
the disulfides and NTR. The two CSDs are the two nested disulfides in
the NTR region. The NTR region comprising residues 1–55 is typically
deleted in yeast functional assays. An equivalent region is typically deleted
in ERO1α (Hansen et al., 2012). Interestingly, this region is not generally
deleted in ERO1B (Pagani et al., 2000).
The phylogenetic tree for ERO1, built from 119 sequences
is shown in Figure 4A. Originally present as a single gene,
ERO1 duplicated prior to the divergence of bony fishes. The
single gene in organisms predating bony fishes is generally
termed ERO1-like (ERO1L) because it is clearly homologous
to yeast ERO1 but has diverged in some crucial aspects,
for example the yeast sequence has a long C-terminal tail.
Yeast ERO1 has diverged sufficiently from human ERO1 that
a meaningful sequence alignment over the full mask region
employed for the phylogenetic tree is not possible. Of the dupli-
cated daughters, ERO1A is ubiquitously expressed. This gene
is located on chromosome 14 in humans. The other daugh-
ter, ERO1B, expressed in secretory tissues such as the pan-
creas, is found on chromosome 1 in humans. In metazoan
ERO1L and ERO1A, the NTR has four Cys residues homol-
ogous to the CSD residues of human ERO1A, suggesting the
CSDs are conserved across the group. In ERO1B, the four
Cys are retained in the NTR of fishes and sharks, but only
two Cys, homologous to those forming the inner CSD, are
present in ERO1B of amphibians and higher teleosts. The
presence of four Cys or two Cys in the NTR of ERO1B
homologs partitions with sea and land animals respectively.
Similar to ERO1B, in yeast ERO1, only the inner Cys pair is
present.
What is the significance of Cys mutations in the NTR to the
function of ERO1 homologs? As proteins rich in disulfides are
highly expressed in secretory organs, the cells in these tissues are
more susceptible to ER stress. Thus, ERO1B is likely to be under
increased demand for disulfide formation in the secretory tis-
sues where it is expressed compared to ERO1 homologs in other
tissues. In addition, the emergence of animals onto land likely
increased the importance of secretory organs in dealing with the
effects of dehydration. The fact that one of the CSDs is lost in the
NTR of ERO1B found in secretory tissues of land animals, sug-
gests its loss is associated with increased activity of ERO1B. This
suggests the NTR may have a role in inhibition of ERO1. The loss
of the outer CSD of ERO1B in land animals may have resulted
in decreased inhibition, allowing these organisms to cope with
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the greater demands for disulfide bond formation in their secre-
tory organs. The fact that NTR-deletants are typically used for
functional assays of ERO1A and yeast ERO1 is consistent with this
hypothesis.
AKT
Kinases of the AKT family are cytoplasmic proteins forming
essential components in growth factor signaling pathways,
activated downstream of the membrane-bound phospho-
inositol-3 kinase (PI3K). The AKT genes are serine/threonine-
protein kinases involved in regulating many processes such as
metabolism, proliferation, cell survival and growth, and angio-
genesis. AKT1 (RAC-α) is encoded on chromosome 14 of the
human genome. AKT2 (RAC-β), which acts in the insulin sig-
naling pathway, is encoded on chromosome 19. Both AKT1 and
AKT2 are activated by platelet-derived growth factor. AKT3 is
expressed in the brain.
The protein consists of three domains: an N-terminal
Pleckstrin homology (PH) domain, a protein kinase domain, and
a C-terminal AGC kinase domain. The PH domain is involved
in membrane targeting of AKT via binding of phospholipids.
The CSD is formed between Cys 60 and Cys 77 in the PH
domain (PDB: 1unr). Crystallographic evidence supports redox
activity of the disulfide (Fan et al., 2009). The reduced struc-
ture is PDB 1unq. It undergoes a morphing transition: a plastic
deformation involving a large-scale conformational rearrange-
ment of the polypeptide backbone which is likely regulated by
redox activity of the CSD (Fan et al., 2009). Cys 77 can be modi-
fied by methylglyoxal to form an advanced glycation end product
(AGE). Methylglyoxal is a byproduct of several metabolic path-
ways including threonine metabolism, lipid peroxidation and
glycolysis.
Like CD4, AKT has multiple redox-regulated thiol sites. In
AKT2 a redox-regulated order/disorder transition, modulated by
reduction of the Cys 297/Cys 311 disulfide in the T loop, con-
trols exposure of a key phosphorylation site at Thr 309 (Huang
et al., 2003; Fan et al., 2009). Formation of the T loop disulfide is
proposed to inhibit kinase activity by recruiting the cognate phos-
phatase (Leslie, 2006). Grx reduces AKT, although it is not clear
whether it acts at the CSD, the T loop disulfide, or some other site
(Murata et al., 2003). Modification of Cys 77 by methylglyoxal
results in activation of AKT1, promoting proliferation of vascular
smooth muscles (Chang et al., 2011). Overexpression of an AKT1
Cys77Ser mutant increased cell proliferation and DNA synthesis
which could not be augmented by methylglyoxal treatment like
the wild-type.
The phylogenetic tree for AKT built from 262 sequences is
shown in Figure 5. The AKT gene has triplicated from the original
ancestor: The original AKT-like (AKTL) gene is found in metazoa
ranging from C. elegans to lamprey. An initial duplication, occur-
ring after the divergence of lamprey, a jawless fish, was followed
shortly after by a second duplication. AKTL genes predominantly
have a single N-terminal Cys, for example all arthropods; but
orthologs exist with no Cys (clade Q—eye worm, pig round worm
and pinewood nematode worm; and the red flour beetle within
cladeW, Coleoptera); and a single C-terminal Cys (clade R-C. ele-
gans, pole worm and nematode worm, clade O—Sea squirt).
Clade N is the earliest metazoan with both Cys of the CSD. This
group includes the hemichordate acorn worm and a placazoan, a
basal form of invertebrate. Lamprey is the highest organism con-
taining a single AKT gene with both Cys of the CSD. Subsequent
to the divergence of lamprey the AKT gene underwent a trip-
lication, with all daughters: AKT1, AKT2, and AKT3, retaining
the CSD.
PHYSICOCHEMICAL PROPERTIES OF THE CSDs
The physicochemical properties of the CSDs of interest to this
study are listed in Table 1, along with those of three control
disulfides. Two positive controls are barley α-amylase/subtilisin
inhibitor (BASI) Cys 144–Cys 148, a CSD which is a preferred
substrate of Trxh; and DsbD Cys 103–Cys 109, a CSD which is
the active site disulfide in the N-terminal domain of DsbD, which
is reduced in vivo by the Trx-like C-terminal domain of DsbD.
A negative control is BASI Cys 43–Cys 90 which is reduced by
Trxh, but is not a preferred substrate (Maeda et al., 2006). All
the CSDs adopt the right-handed staple conformation and have
medium torsional energies (10–17.5 kJ.mol−1) typical of CSDs,
except the outer disulfide of the ERO1 nested pair. This disulfide
between Cys 35 and Cys 48 adopts a much higher energy cis GGS′
conformation (Haworth et al., 2007). Its extremely high torsional
energy is consistent with an auto-reduction process; the Cys of
this disulfide could potentially isomerize with Cys 37 and Cys 46
or may even be mechanically reduced. The negative control in
BASI between Cys 43 and Cys 90 is a low energy disulfide in a
right-handed spiral conformation, typical of structural disulfides
(Haworth et al., 2007). In summary, with the exception of the Cys
35–Cys 48 CSD of ERO1, all the CSDs in the proteins of interest
had conformations and torsional energies consistent with CSDs
which are preferred substrates of Trx-like enzymes.
Finally, we attempted to assess the likelihood that the reduced
form of the protein of interest was a likely target of ROS/RNS; and
which of the Cys was more likely to be modified. This was only
possible for the PH domain of AKT. The controls we used were
reduced forms of Trx-like enzymes and other proteins known to
be modified by GSH. The results are shown in Table 2. The pKas
of the active Cys in Grxs were generally between 7 and 8, while Cys
in proteins which are modified by GSH were between 10 and 11.
The values calculated for AKTwere in the same range as GSH sub-
strates. From the point of view of pKa, both Cys are equally likely
to be attacked by ROS/RNS. However, other considerations may
be important in vivo such as solvent accessibility of the individual
Cys i.e., whether it is buried or accessible.
DISCUSSION
Disulfide bonds between Cys residues are generally thought to
confer extra rigidity and stability to their resident protein, form-
ing a type of proteinaceous spot weld. The conundrum of disul-
fides as structural stabilizers is how the two Cys residues could
have been introduced into the protein chain simultaneously. A
possible explanation is suggested by the emerging paradigm that
the disulfide proteome consists of two subproteomes: a structural
group and a redox-sensitive group (Yang et al., 2007). For struc-
tural disulfides, both Cys are functionally required. However, a
single Cys residue can form a redox-sensitive site on a protein.
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FIGURE 5 | Evolution of AKT genes showing the presence of the CSD.
Colors of branches denote the number of Cys residues homologous to
those of the CSD present in each species. Reversion to a single C-terminal
Cys in the Chinese tree shrew is accompanied by rapid diversion of the
sequence from other mammalian sequences. Keys to branches A,
Mammals, birds, reptiles; B, Fishes; C, Sea lamprey; D, Mammals; E,
Snakes; F, Spotted gar, salmon, and fishes; G, Frogs; H, Elephant fish; I,
Zebra fish; J, Mammals; K, Tasmanian devil, Opposum, Turtle, and Birds;
L, Frog and Coelacanth; M, Fishes; N, Acorn worm; O, Sea squirt; P,
Trichina worm; Q, Eye worm, Pig round worm, and Pinewood nematode
worm; R-C. elegans, pole worm and nematode worm; S-Y-Arthropods
including Lepidoptera (T) and Diptera (U,V).
Table 1 | Dihedral angles calculated for the disulfides of interest in the proteins studied with the torsional energies and their respective
conformations.
Protein PDB code Disulf χ1 χ2 χ3 χ
′
2 χ
′
1 Torsion energy Conf. Motif
kJ/mol
AKT 1unr 60–77 −52.3 −120.5 105.2 −82.6 −50.9 13.9 Staple CSD
ERO1 3ahq 35–48 −54.3 −121.9 45.8 75.6 176.7 36.9 cis CSD
ERO1 3ahq 37–46 −61.3 −79.9 110.1 −102.8 −58.8 11.7 Staple CSD
CD4 4h8w 130–159 −67.0 −86.3 108.2 −91.1 −58.6 11.7 Staple CSD
+BASI 1ava 144–148 −63.2 −93.9 115.6 −78.1 −71.0 12.5 Staple CSD
−BASI 1ava 43–90 −60.1 −73.5 −89.3 −73.6 −67.0 1.6 Spiral –
+DsbD 1jpe 103–109 −51.0 −116.4 92.1 −77.8 −72.8 13.8 Staple CSD
Thus, a redox-active disulfide may be introduced into a pro-
tein structure by stepwise mutation of two residues in the native
sequence to Cys. By extension, evolutionary acquisition of struc-
tural disulfides in proteins can potentially occur via transition
through a redox-active disulfide state.
Alternatively, a fully-fledged disulfide of either type could be
acquired via a retrotransposon. Indeed, introduction of another
type of redox site, the four Cys zinc (Zn2+) binding site (Wouters
et al., 2010), into proteins appears to largely have been effected
by retrotransposons (Babu et al., 2006). A hallmark of this
type of acquisition is insertion of a sequence fragment. In the
case of Zn fingers, the fragment is around 30 amino acids in
length.
The cases of CSD acquisition here clearly do not involve
insertion of a sequence fragment, as evidenced by the sequence
alignment. Instead, the redox switch was introduced by stepwise
mutation of two residues in the native sequence to Cys. The
advantages of acquisition of the CSD to protein function are
clearly demonstrated by the retention of the redox switch in
higher organisms. It is interesting to note that triplication of the
AKT gene occurred after acquisition of the CSD, and it remained
encoded in all daughter genes, suggesting it is integral to the
function of these genes. In some species or homologs, the CSD
acquisition process appears to have reversed. For example, in
ERO1B, one of the CSDs was lost in secretory tissues of land
animals.
Do the two Cys need to be acquired in a particular order dur-
ing the evolutionary process? In order to be glutathionylated,
a minimum requirement is that the Cys has a low pKa. When
two disulfide-forming Cys are present, the Cys with the lower
pKa is generally termed the “active” Cys (Figure 1), because it is
the one targeted by ROS/RNS. The second Cys, which prevents
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Table 2 | Calculated pKas for AKT and control proteins.
Protein Cys PDB pKa
ScGrx6 136 3l4n 7.42
StGrx2 9* 3ir4 7.11
HsGrx2 37 2fls 8.01
HsCLIC1 24 1k0n 9.43
SpGST 10* 1f2e 11.56 ± 0.24
PmGST 10* 1pmt 11.07
BxGST 10 2dsa 17.29 ± 0.05
HsGSHR 58* 1dnc 9.52 ± 0.11
TttRNA methyltransferase 223 3g5s 10.09
Rncarbonic anhydrase 183* 1flj 10.57
AKT 60 1unq 11.35
AKT 77 1unq 11.03
*Indicates the proteins where GSH was removed from Cys for calculation.
Standard error was calculated where required.
FIGURE 6 | Location of CSDs in the secondary structure of the proteins
studied according to PDB structures: CD4—4h8w, ERO1—3ahq, and
AKT—1unr. The Cys on the orange strand is the putative active Cys for
each protein. Trx/Grx must bind as an extra strand near the active Cys as
shown for AKT. In ERO1 and CD4, this site is protected by an additional
strand (strand G in both CD4 and ERO1), which must be displaced to allow
access by Trx. For CD4 to become accessible to Trx/Grx, one of the hairpins
must hinge open to allow Trx/Grx to dock in place of the strand as shown in
the hypothetical CD4∗ diagram.
overoxidation of the active Cys by disulfide formation, is termed
the “resolving Cys.” However, the pKas of the two Cys are not
easily discerned from a protein structure and are generally deter-
mined experimentally. In addition, the structural requirements
of Grx and Trx docking are such that the active Cys should be
on an edge strand (Figure 6). Thus, by the simplistic hypothe-
sis depicted in Figure 1, the low pKa Cys should be introduced
into the protein first and be mutated from the protein last; and it
should be on an edge strand. How does this hypothesis stack up
with the three proteins studied here? The relevant information is
summarized in Table 3.
Table 3 | Contexts of CSD residues in proteins of interest.
Protein N-Cys Edge? C-Cys Edge? Environment
CD4 130 No 159 No Cell surface
ERO1 35 No 48 Yes ER
ERO1 37 No 46 Yes ER
AKT 60 Yes 77 No Cystosol
The table is based on PDB structures 1unr (AKT), 4h8w (CD4), and 3ahq (ERO1).
The most common 1-Cys residue in the sequence alignments is bolded. This is
likely to be the “active” Cys.
Of the three molecules, only AKT can dock Grx/Trx in the
manner suggested, as shown in Figure 6. However, of the three
molecules, AKT is the only cytosolic protein and thus would
be found in the reduced state under normal physiologic con-
ditions. Thus, consideration of the cellular compartment is an
additional complication. Oxidation of a cytosolic molecule, pro-
moting formation of the disulfide-bonded form, will only occur
under conditions of oxidative stress. Disulfide bond formation in
the pleckstrin-homology domain of AKT is likely associated with
membrane targeting of AKT under conditions of oxidative stress
(Fan et al., 2009). The likelihood that Cys 60 is the active Cys
of the AKT CSD is supported by studies which demonstrate its
modification in experiments on growth factor signaling (Antico
Arciuch et al., 2009). On the other hand, CD4 and ERO1 exist
in oxidative environments where the disulfide bond would be
formed in the latent state: CD4 is cell surface protein of the blood
plasma; ERO1 is an ER-resident protein.
Only in the cytosolic protein AKT, where the disulfide is nor-
mally in the reduced state, is the protein readily accessible by Trx.
In CD4 and ERO1, the putative Trx-binding site is blocked by
an additional strand. In CD4, the additional strand G is formed
by residues 166–172 (PDB: 4h8w). In ERO1, strand G is formed
by residues 355–359. Protection by an additional strand may be
a general feature of CSDs in oxidative environments to prevent
adventitious reduction of the CSD.
Because the disulfides in ERO1 and CD4 are latently oxi-
dized, it is likely that Trx is only given access to the site under
special conditions. For example, in CD4 the site becomes acces-
sible during T-cell signaling. It has been proposed that CD4
undergoes domain swapping to facilitate this reduction (Matthias
et al., 2002), a process that involves rearrangement of β strands.
We speculate on the nature of this process in CD4 below. The
latently oxidized states, are thus likely “occult” Trx-binding sites
which must be unmasked by conformational changes prior to Trx
binding and disulfide reduction (Wouters et al., 2010).
Several other proteins containing CSDs domain swap suggest-
ing a relationship between domain swapping and CSD reduction
(Wouters et al., 2010). GSH bindingmay also be related to domain
swapping: GSH binding to Cys 60 of glyoxalase I regulates domain
swapping in this protein (Saint-Jean et al., 1998).
EVOLUTION OF CD4
Several evolutionary studies of CD4 have examined the non-
synonymous/synonymous substitution rate (ω = dN/dS) in
order to determine which regions of the CD4 molecule are under
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positive selection. Non-synonymous changes are nucleotide
codon changes that alter the amino acid coded at the protein
level, while synonymous changes alter the nucleotide while
preserving the amino acid. These studies found that CD4 is
evolving rapidly under positive selection. In a pairwise com-
parison of human and mouse CD4, Ansari-Lari et al. (1998)
determined ω = 0.77, much higher than the average of ω = 0.12
determined for ∼13000 pairs of human/mouse orthologs. A
study of primate CD4 sequences identified positive selection
(ω > 1) throughout the molecule, but chiefly in the N-terminal
region corresponding to D1 and D2 (Zhang et al., 2008). The
sequence up to residue ∼153, which includes the first Cys residue
of the CSD, has stronger selection than average for the molecule
(ω > ω−= 1.17).
Our study shows that the relatively rapid evolution of CD4 is
predominantly focused on acquisition and modification of thiols
involved in redox signaling. CD4 is an interesting molecule from
the point of view of evolution of thiol-based redox signaling.
All three known protein-protein interaction sites contain impor-
tant cysteine residues. The primordial cysteine site: the CXC
motif found in the cytoplasmic tail, is not found in the ances-
tral gene LAG3. This motif mediates the interaction with p56LCK
necessary for T cell activation (Laing et al., 2006).
A second site is the CSD in D2, which is the subject of this
study. This is the primary recognition site for HIV gp120 and
a co-recognition site for MHCII molecules. The independent
acquisition of the CSD in two clades, primates and muroids,
at roughly the same epoch ∼75 MYA is interesting, and could
arise from an environmental change, for example in the oxy-
genation of the Earth’s atmosphere. This date is not long after
the KT extinction, the global event that wiped out the dinosaurs
around 80 MYA. Alternatively the dual acquisition might have a
biological origin e.g., challenge by a common parasite or infec-
tious agent. Mammals evolved during an interesting period of the
earth’s history with respect to continental drift. During the cre-
ataceous period, the super-continent Gondwana broke up. Given
the co-location of the two clades involved on the same continent,
the second “biological challenge” hypothesis seems attractive.
The pairwise sequence alignments show the CSD site has been
undergoing rapid evolution since its introduction in both clades
(Figure S2).
The third protein-protein interaction site bearing important
Cys residues is located in D1. Interestingly, in a process similar to
step 1 of the CSD evolution in D2, modification of the canonical
Ig disulfide between strands B and F has also occurred in D1 of
some fish CD4 proteins (trout and fugu), which contain a distinct
unpaired Cys in strand F, but lack the second Cys in strand B that
forms a disulfide in mammalian and bird CD4 molecules.
Finally, LAG3 is very similar to CD4 but lacks the LCK bind-
ing site (Laing et al., 2006) (α in Figure 2B). Functionally LAG3
interacts with MHCII with higher affinities than CD4, and may
have a role in impeding access to MHCII of CD4 (Workman
et al., 2002; Workman and Vignali, 2003). The two Ig-domain
molecule CD4REL (β in Figure 2B) appears to be a progenitor
of CD4 which is also found in the lamprey a vertebrate which
diverged earlier than fish. The lamprey genome does not contain a
CD4 ortholog (γ in Figure 2B). Trout contains both CD4REL and
CD4, but vertebrates that evolved later, such as the chicken, do not
appear to have a CD4REL-like molecule, retaining only CD4.
Thus, CD4 arose de novo in fish around 450 MYA around the
time its primary tissue of origin, the thymus, appeared in ani-
mals. Originally containing the important cytosolic CXC motif,
CD4 then underwent rapid evolution at two distinct protein-
protein interaction sites in D1 and D2, both bearing important
Cys residues.
Speculations on activation of CD4 by HIV gp120
Given the importance of CD4 CSD reduction in the entry of HIV
gp120 into the cell, it is worth speculating on the nature of this
process in the light of the hypothesis put forward here. Sheet 1
in D2 of CD4, which consists of residues 99–119 and 142–146,
can be considered as the “torso” of D2 from which two β-hairpin
“arms” are extended, comprising residues 127–140 (N-arm) and
residues 157–172 (C-arm). These “arms” are clasped together by
a series of hydrogen bonds and the disulfide formed between
Cys 130 and Cys 159 on strands C and F to form the second
sheet. In domain swapping, either one or both of these arms may
be exchanged with an adjacent CD4 molecule. This can only be
achieved by breakage of the C-F hydrogen bonds and reduction
of the CSD between Cys 130 and Cys 159. In its location on the
interior strands of the four-stranded sheet 2, the CSD is protected
from interaction with Trx and Grx. However, it may be accessi-
ble by GSH. In order to become accessible to Trx/Grx, one of the
hairpins must hinge open, to allow Trx/Grx to dock in place of the
strand. As Cys 159 is conserved in all CD4 molecules, it is likely
the “active Cys.” Thus, docking of Trx/Grx may be effected by
peeling away the C-terminal strand (G) from the molecule (CD4∗
in Figure 6). Thus, we propose this is a necessary “priming” step
for CD4 CSD reduction.
CONTEXT-DEPENDENCE OF Cys INCORPORATION IN PROTEIN
SEQUENCES
Early studies on protein sequences indicated Cys is more abun-
dant in more complex organisms (Fahey et al., 1977; Miseta and
Csutora, 2000). This has been confirmed by more recent stud-
ies on whole genomes that have shown the abundance of Cys
in proteins has been increasing since divergence from the Last
Universal Common Ancestor (Woese, 1998; Brooks and Fresco,
2002); and this increase is a continuing panspecies phenomenon
which is evident within the last 10 million years (Jordan et al.,
2005). It seems likely that increased Cys abundance arises from
increased use of thiol-based redox signaling in more complex
organisms. Although the prevalence of Cys in proteins is increas-
ing, the abundance has not yet reached the neutral frequency (i.e.,
the frequency that would be expected based on the number of
Cys codons in the genetic code) (King and Jukes, 1969; Brooks
and Fresco, 2002). The failure of Cys to reach its equilibrium fre-
quency suggests that incorporation of additional Cys into proteins
may come at a cost: increased signaling and control may be gained
at the cost of deleterious effects of over-oxidation (Wouters et al.,
2010).
This study suggests that successful incorporation of Cys may
be limited to very select contexts in proteins, specifically those
where reduction of the Cys can be effected by enzymes of redox
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homeostasis. In this study, the successfully incorporated sites are
likely reduced by Trx-like enzymes. The disulfide bond in CD4 is
reduced by Trx (Aniksztejn et al., 1987; Matthias et al., 2002), and
the disulfide in AKT may be sensitive to Grx (Murata et al., 2003;
Wang et al., 2007).
If a Cys that is modifiable by GSH is in a place which cannot
be accessed by Grx, the protein will likely be targeted for removal
by the GSH detoxification system. Thus, the mutation most likely
will have a deleterious effect on protein function by inducing a
state of haploinsufficiency. If the Cys is in a place where it may be
reduced by Grx, introduction of the Cys does not have a deleteri-
ous effect on protein function because it may be removed. If, in
addition, it is introduced in a place which modulates the protein’s
function in a way which is beneficial to redox function, it may
become fixed in the population. For example, if addition of GSH
temporarily prevents a protein interaction that would be delete-
rious under conditions of oxidative stress. Thus, only 1-Cys GSH
switches that are beneficial to physiologic function are likely to be
retained in the population sufficiently long for random mutation
of a second Cys to occur; and this second mutation must also be
sufficiently beneficial to be retained over the 1-Cys variant.
CONVERGENT ACQUISITION OF MODULAR REDOX SWITCHES
Before multiple genome sequences were complete, it was gener-
ally believed increased complexity of organisms correlated with
gene number. After completion of the first genomes, the small
differences in gene number between simple unicellular eukaryotes
and mammals forced revision of how complexity is encoded. For
example, the yeast genome contains 5000 genes, yet the human
genome contains only five times more: 25,000. Additional com-
plexity at the organismal level is likely encoded at the molecular
level by noncoding DNA, as this is considerably different between
these organisms (Mattick, 2004).
However, increased complexity may also be encoded at the
protein level. It was previously recognized that concatenation
of existing domains through gene fusion, also known as pro-
tein domain mosaicism, encodes new functions in more complex
organisms (Patthy, 1985). Studies on the changing amino acid
content of proteins show that domains also are not static struc-
tures. Additional complexity added to protein domains in the
form of redox and other switches likely increases the signaling
capabilities of individual domains. In other words, nature is con-
tinually tinkering with these independent folding units: a domain
from archaea may not have the same sophisticated set of switches
as the homologous domain from a mammalian protein.
Thus, two modes of acquisition of increased protein complex-
ity have been demonstrated to date: protein domain mosaicism
(Patthy, 1985), and acquisition of allosteric control sites.
Previously, Babu et al. (2006) showed that Zn finger allosteric
control sites are added to protein sequences via retrotransposons.
Here we studied a novel method of acquisition of an allosteric
control site: formation of CSDs by stepwise acquisition of Cys
residues in appropriate contexts. Both these Cys-based sites, Zn
fingers and CSDs, are known to be redox regulated.
In this study, we analyzed incorporation of disulfide-
based redox switches into three protein families. Successful
context-dependent stepwise evolution of the sites likely enabled
the proteins to utilize existing Trx-like enzymes to mediate suc-
cessful incorporation into cellular mechanisms of redox home-
ostasis. Thus, three non-homologous proteins have convergently
acquired the same modular redox switch: the CSD. CSDs are,
by far, the most common forbidden disulfide found in homol-
ogous sites of protein structures (Wouters et al., 2010). They have
evolved independently multiple times. CSDs have been postu-
lated to have special redox properties: specifically intermediate
torsional energies that enable them to be reduced in a con-
trolled process by other thiol sites in proteins. However, many
other forbidden disulfides share this property, so this does not
explain why evolution of CSDs is favored over other forbid-
den disulfides. Work by Maeda et al. (2005), which suggests
that a CSD in BASI is specifically recognized by Trx; and our
own bioinformatic work, which has identified multiple CSDs
which undergo redox reactions with the CXXC motif of Trx-like
enzymes, suggest that CSDs are cognate substrates of Trx-like
enzymes (Haworth and Wouters, 2013). Although Trxs recognize
multiple non-homologous substrates, solved protein structures of
disulfide-linked Trx-substrate reaction intermediate mimics have
provided evidence for recognition of structural motifs in tar-
get proteins by Trxs (Qin et al., 1995, 1996; Maeda et al., 2006;
Chartron et al., 2007).
Although BASI has nine disulfides, only two are specifically
targeted by Trxh (Maeda et al., 2005). Cys 144–Cys 148 and Cys
43–Cys 90. Of these two, Cys 144–Cys 148, which is a CSD, is
much more efficiently reduced. The specificity of the reaction is
partly ensured by consistent docking of the substrate. In most
solved protein structure complexes, Trx-like molecules bind their
substrates as an antiparallel β-strand. The interaction between Trx
and its substrate is characterized by three distinctive hydrogen
bonds of a pattern typically found between pairs of antiparallel β-
strands. A similar pattern of hydrogen bonds is observed between
the N-terminal Trx-like domain of Escherichia coli DsbD in com-
plex with the C-terminal domain of DsbD which contains the
CSD (Cys 103–Cys 109) substrate (Rozhkova et al., 2004). This
suggests the evolution of CSDs is favored over other forbidden
disulfides because they can be immediately exapted from the Grx
to the Trx redox homeostasis pathways.
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